global campaign for microbicides business and hiv/aids, tb & malaria : june 19-20, 2008 neeraj...
TRANSCRIPT
![Page 1: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/1.jpg)
Global Campaign for Microbicides
Business and HIV/AIDS, TB & Malaria :
June 19-20, 2008
Neeraj Mistry MD, MPH
![Page 2: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/2.jpg)
Overview
Health and Safety momentBusiness and AIDSGBCExamples of Corporate
EngagementWorkplace programs
![Page 3: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/3.jpg)
Health & Safety Moment
![Page 4: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/4.jpg)
Member Companies
![Page 5: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/5.jpg)
The Business Case
Workforce &Productivity
Corporate Social
Responsibility
Consumer & Political
Expectations
Shrinking,
Riskier Markets
CorporateHIV/AIDS, TB & Malaria
initiatives
© gbc 2005
![Page 6: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/6.jpg)
• Health of workers and customers• Stability of countries and markets• Brand value• Ability to attract and retain talent• Credibility (“license to operate”)
– With the public sector– With society
Business is motivated by self-interest, social conscience
![Page 7: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/7.jpg)
The Impact on Business:Declining Productivity
and Profits•Increased cost for health care, burials, training and recruitment of replacement employees•Decreased productivity and revenues as a result of absenteeism due to illness or attendance at funerals•Employees in their most industrious years are affected most•As AIDS prevalence rises, GDP falls. •In Sub-Saharan Africa:
•Prevalence of 8% results in GDP decrease of 1%•Prevalence of 10%, results in GDP decrease of over 30%•1/3 of the regions countries have HIV prevalence of 8% •HIV/AIDS is projected to reduce the size of the labor force in 32 African countries by 5–35% by 2020
•HIV/AIDS threatens GDP growth in Brazil, China, India, and Russia.
•China’s GDP growth may decrease by 1% over 10 years •Russia’s GDP growth may decrease by 4% by 2010 and 10% by 2020
![Page 8: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/8.jpg)
AIDS Decimates Economies
-1.6
-1.4
-1.2
-1
-0.8
-0.6
-0.4
-0.2
0
0 5 10 15 20 25 30 35
HIV Prevalence Rate (%)
Growth Impact of HIV (1990-97) for 80 developing countries
Source: R. Bonnel (2000) Economic Analysis of HIV/AIDS, ADF2000 Background paper, World Bank. Slide adapted from UNAIDS: “Socio-Economic Impact of HIV/AIDS in Africa,” presented by Anita Alban and Lorna Guiness, ADF 2000.
Red
uctio
n in
gro
wth
rat
e G
DP
pe
r ca
pita
(%
, p
er y
ear)
![Page 9: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/9.jpg)
Companies Speak
![Page 10: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/10.jpg)
GBC Member Companies
![Page 11: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/11.jpg)
• Business skills improve effectiveness of government, NGO, and local initiatives
• Business has direct access to millions • Business provides outreach mechanisms
– Employees– Customers– Suppliers– Distribution chains
• Business relationships help clear hurdles• Business is willing to invest• Shell - Nigeria
Business know-how, access makes critical difference
![Page 12: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/12.jpg)
GBC
• 220 companies working to maximize their impact in the fight against HIV/AIDS, tuberculosis, and malaria
• GBC’s four main goals facilitate its mission to harness the power of the global business community to end the HIV/AIDS, tuberculosis, and malaria epidemics:
• Increase the number and diversity of companies committed to fighting global epidemics
• Increase business action against HIV/AIDS, TB, and malaria, and improve the quality and reach of company and community programs
• Enhance and facilitate the use of companies' core competencies and products in the fight against HIV/AIDS, TB, and malaria
• Use business power to advocate for HIV/AIDS, TB, and malaria issues and lead the epidemic’s response
![Page 13: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/13.jpg)
Business in Action
• Workplace
• Community
• Core Competency
• Co-Investment
• Advocacy & Leadership
• Innovation
![Page 14: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/14.jpg)
…in the Workplace
• In 2003, VWSA worked with GTZ to develop an integrated HIV/AIDS workplace program
• The 2 main components are prevention of HIV and treatment with ARVs
• The program has been extended to the families of employees
• Two years into the program, VWSA has launched a program performance evaluation in order to assess impact
![Page 15: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/15.jpg)
…in the Community
• Developed local labs for HIV monitoring and research
• Created a training curriculum and exchange program for African nurses and doctors
• Hosts community programs to address AIDS orphans, home care, and counseling
•Joined with 4 other pharmaceutical companies and UNAIDS on a treatment access initiative
![Page 16: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/16.jpg)
…with its Core Competency
All the profits from the Viva
Glam Line goes to AIDS research - over $50 million
to date
![Page 17: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/17.jpg)
…Co-Investment
• Co-Investment / Private-Public Partnerships
- Brings together various sectors with unique and complementary resources
- Four pilot projects: -Nigeria (2)-Kenya-South Africa
- $1.4 million investment by PEPFAR- “Making Co-Investment a Reality”
produced with GTZ
Development Goals
Private Sector Goals
PPP
![Page 18: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/18.jpg)
Through Virgin Unite, Richard Branson has used his celebrity status to inspire action by Virgin employees,
consumers, and other business leaders.
…through Advocacy &Leadership
![Page 19: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/19.jpg)
Getty Images uses the undeniable power of imagery to put a human face on HIV/AIDS. It provides its
photographs - taken in the hardest-hit regions of the world - to organizations and companies.
.…through Innovation
![Page 20: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/20.jpg)
The GBC Response
What we do & how we do it:
![Page 21: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/21.jpg)
Global Trends in Business Action
• Workplace-Community Continuum
• Collective actions – PPPs, B2B (GBC Impact Initiatives)
• Integrated responses – AIDS, TB, Malaria
• Competition/Collaboration with other global issues – climate, sustainable development, health systems strengthening…
• Increasing Donor Community interest
• Gender Training and Programs
• Cause-related Marketing – (Product)RED
• Cash Contributions – Global Fund Corporate Champions
![Page 22: Global Campaign for Microbicides Business and HIV/AIDS, TB & Malaria : June 19-20, 2008 Neeraj Mistry MD, MPH](https://reader036.vdocuments.site/reader036/viewer/2022062421/56649e025503460f94aed01b/html5/thumbnails/22.jpg)
Thank You!
Questions and
Discussion